FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 39 filers reported holding FUSION PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,000 | +22.2% | 4,204 | +128.6% | 0.00% | – |
| Q2 2023 | $9,000 | +12.5% | 1,839 | -16.5% | 0.00% | – |
| Q1 2023 | $8,000 | +166.7% | 2,203 | +159.2% | 0.00% | – |
| Q4 2022 | $3,000 | 0.0% | 850 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 850 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -71.4% | 850 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | +75.0% | 850 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -78.9% | 850 | -63.8% | 0.00% | – |
| Q3 2021 | $19,000 | +111.1% | 2,350 | +104.3% | 0.00% | – |
| Q2 2021 | $9,000 | +200.0% | 1,150 | +267.4% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 313 | +4.3% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,379 | $12,659,000 | 4.47% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $23,347,000 | 3.00% |
| JOHNSON & JOHNSON | 3,670,516 | $29,070,000 | 2.55% |
| Sio Capital Management, LLC | 259,763 | $2,057,000 | 0.66% |
| Orbimed Advisors | 3,224,770 | $25,540,000 | 0.28% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20,210,000 | 0.20% |
| Rock Springs Capital Management LP | 948,327 | $7,511,000 | 0.16% |
| Perceptive Advisors | 1,254,607 | $9,936,000 | 0.14% |
| AlphaCentric Advisors LLC | 71,500 | $566,000 | 0.14% |
| Artal Group S.A. | 750,000 | $5,940,000 | 0.13% |